Back to All Events

Mastering the new diagnostic pathway: the ERS/ATS clinical practice guideline for PCD

Overview

This one-hour webinar will provide a practical introduction to the newly published joint ERS/ATS evidence-based guideline for the diagnosis of primary ciliary dyskinesia (PCD) (Eur Respir J 2025;66:2500745). As most individuals with PCD remain undiagnosed despite the clear benefits of early diagnosis for both children and adults, this educational session aims to support clinicians in implementing the new guideline in routine practice.

Participants will gain an understanding of the updated diagnostic algorithm, which places genetic testing at the centre of the diagnostic pathway while integrating transmission electron microscopy, nasal nitric oxide measurement, high-speed video-microscopy, and immunofluorescence as complementary investigations. Through expert presentations, interactive clinical cases, and a panel discussion, attendees will learn how to recognise patients who should be referred for diagnostic testing, interpret the results and limitations of the core diagnostic investigations, and apply the guideline to complex clinical scenarios to guide decision-making.

The webinar, chaired by Adam Shapiro, will feature presentations by Amelia Shoemark, Amjad Horani, Thomas Ferkol, and Panayiotis Kouis, followed by a live question-and-answer session.

Registration and information on ERS Respiratory channel


Previous
Previous
1 July

World Bronchiectasis Day Question Time

Next
Next
19 August

Global PCD conference 2026